|
S1267
|
Vemurafenib (PLX4032) |
PLX4032 (Vemurafenib, RG7204, Zelboraf, RO5185426) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM. |
|
|
|
S1040
|
Sorafenib (Nexavar) |
Sorafenib Tosylate (Bay 43-9006, Nexavar) is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively. |
|
|
|
S1178
|
Regorafenib (BAY 73-4506) |
Regorafenib (BAY 73-4506, Fluoro-Sorafenib) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively. |
|
|
|
S1152
|
PLX-4720 |
PLX-4720 is a potent and selective inhibitor of B-RafV600E and c-Raf-1Y340D/Y341D with IC50 of 13 nM and 6.7 nM, respectively. |
|
|
|
S2807
|
Dabrafenib (GSK2118436) |
Dabrafenib (GSK2118436) is a potent ATP-competitive inhibitor of B-Raf, B-RafV600E and c-Raf with IC50 of 3.2 nM, 0.8 nM and 5.0 nM, respectively. |
|
|
|
S7121
|
MLN2480 |
MLN-2480 (BIIB-024) is a pan-Raf inhibitor. |
|
|
|
S7001
|
PF-04880594 |
PF-04880594 is a RAF inhibitor for BRAF and c-RAF with IC50 of 0.19 nM and 0.39 nM, respectively. |
|
|
|
S1104
|
GDC-0879 |
GDC-0879 is a novel potent, selective B-Raf inhibitor for B-RafV600E with IC50 of 0.13 nM. |
|
|
|
S2161
|
RAF265 (CHIR-265) |
RAF265 (CHIR-265) is a selective and potent inhibitor of B-Raf and VEGFR2 with IC50 of 3-60 nM and EC50 of 30 nM, respectively. |
|
|
|
S2872
|
GW5074 |
GW5074 is a potent and selective c-Raf inhibitor with IC50 of 9 nM. |
|
|
|
S8015
|
CEP-32496 |
CEP-32496 is a RAF inhibitor for BRAF(V600E), BRAF(WT), c-Raf, Abl-1 and CSF-1R with IC50 of 14 nM, 36 nM, 39 nM, 3 nM and 9 nM, respectively. |
|
|
|
S2746
|
AZ628 |
AZ628 is a potent inhibitor for wild-type CRAF and BRAFV600E with IC50 of 29 nM and 34 nM, respectively. |
|
|
|
S2720
|
ZM 336372 |
ZM 336372 is a potent and selective c-Raf inhibitor with IC50 of 70 nM. |
|
|
|
S2220
|
SB590885 |
SB590885 is a potent B-Raf inhibitor with Ki of 0.16 nM. |
|
|
|
S2202
|
NVP-BHG712 |
NVP-BHG712 is a specific inhibitor of c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM and also inhibits EphB4 and VEGFR2 with ED50 of 25 nM and 4.2 μM, respectively. |
|
|
|
S2200
|
Raf265 derivative |
A derivative of Raf265. But the effects of this derivative is not known. |
|
|